Biological outcomes in disease-modification trials

被引：0
|
作者：
Galasko, D [1 ]
机构：
[1] UCSD, Dept Neurosci, San Diego, CA USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
37
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [41] MEASURING FUNCTIONAL OUTCOMES IN THERAPEUTIC TRIALS FOR CHRONIC DISEASE
    DEYO, RA
    CONTROLLED CLINICAL TRIALS, 1984, 5 (03): : 223 - 240
  • [42] NEUROIMAGING OUTCOMES IN CLINICAL TRIALS IN ALZHEIMER'S DISEASE
    Frisoni, G. B.
    Delacourte, A.
    JOURNAL OF NUTRITION HEALTH & AGING, 2009, 13 (03): : 209 - 212
  • [43] CONSISTENCY OF CARDIOVASCULAR DISEASE OUTCOMES REPORTED IN HAEMODIALYSIS TRIALS
    O'Lone, E.
    Webster, A.
    Sautenet, B.
    Tong, A.
    Craig, J.
    NEPHROLOGY, 2016, 21 : 97 - 97
  • [44] Neuroimaging outcomes in clinical trials in Alzheimer’s disease
    Giovanni B. Frisoni
    A. Delacourte
    JNHA - The Journal of Nutrition, Health and Aging, 2009, 13 : 209 - 212
  • [45] Trials and Treatments for Vascular Brain Health: Risk Factor Modification and Cognitive Outcomes
    Kivipelto, Miia
    Palmer, Katie
    Hoang, Tina D.
    Yaffe, Kristine
    STROKE, 2022, 53 (02) : 444 - 456
  • [46] How should we be using biomarkers in trials of disease modification in Parkinson's disease?
    Vijiaratnam, Nirosen
    Foltynie, Thomas
    BRAIN, 2023, 146 (12) : 4845 - 4869
  • [47] Modeling of Parkinson's Disease Progression and Implications for Detection of Disease Modification in Treatment Trials
    Ribba, Benjamin
    Simuni, Tanya
    Marek, Kenneth
    Siderowf, Andrew
    Diack, Cheikh
    Pierrillas, Philippe Bernard
    Monnet, Annabelle
    Ricci, Benedicte
    Nikolcheva, Tania
    Pagano, Gennaro
    JOURNAL OF PARKINSONS DISEASE, 2024, 14 (06) : 1225 - 1235
  • [48] Lifestyle Modification and Heart Disease Researchers Not Deterred by Trials Showing No Benefit
    Mitka, Mike
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (02): : 150 - 151
  • [49] Systemic sclerosis disease modification clinical trials design: Quo vadis?
    Mendoza, Fabian A.
    Keyes-Elstein, Lynette L.
    Jimenez, Sergio A.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (07) : 945 - 954
  • [50] Endpoints for Clinical Trials Evaluating Disease Modification and Structural Damage in Adults with Crohn's Disease
    D'Haens, Geert R.
    Fedorak, Richard
    Lemann, Marc
    Feagan, Brian G.
    Kamm, Michael A.
    Cosnes, Jacques
    Rutgeerts, Paul J.
    Marteau, Philippe
    Travis, Simon
    Schoelmerich, Juergen
    Hanauer, Steven
    Sandborn, William J.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (10) : 1599 - 1604
12345